Search results
Biogen Inc.'s (NASDAQ:BIIB) Intrinsic Value Is Potentially 97% Above Its Share Price
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights The projected fair value for Biogen is US$508 based on 2 Stage Free Cash Flow to Equity...
Biogen (BIIB) Q4 Earnings & Sales Miss Estimates, Stock Falls
Zacks via Yahoo Finance· 3 months agoBiogen BIIB reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.95, which missed...
Biogen Inc. (NASDAQ:BIIB) is favoured by institutional owners who hold 89% of the company
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Significantly high institutional ownership implies Biogen's stock price is sensitive to...
Biogen's (BIIB) Stock Outperforms Industry YTD: Here's Why
Zacks via Yahoo Finance· 9 months agoWhile most of Biogen's (BIIB) key drugs are facing declining sales, new products, like Leqembi in...
Biogen Rises After 'Drama-Free' Panel Votes Unanimously In Support Of Alzheimer's Drug
Investor's Business Daily· 11 months agoBiogen stock drifted higher Monday after a panel of advisors to the Food and Drug Administration...
Investors in Biogen (NASDAQ:BIIB) have made a respectable return of 35% over the past year
Simply Wall St. via Yahoo Finance· 1 year agoThese days it's easy to simply buy an index fund, and your returns should (roughly) match the...
Biogen (BIIB) Beats on Q3 Earnings & Sales, Cuts EPS View
Zacks via Yahoo Finance· 7 months agoBiogen (BIIB) beats third-quarter estimates for earnings and sales. It lowers its 2023 EPS guidance...
Biogen (BIIB) Beats on Q1 Earnings, Ends Some Research Programs
Zacks via Yahoo Finance· 1 year agoBiogen BIIB reported first-quarter 2023 adjusted earnings per share (EPS) of $3.40, beating the...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance· 4 days agoBiogen BIIB entered into a definitive agreement to acquire private biotech, HI-Bio, for a $1.15...
With 88% ownership, Biogen Inc. (NASDAQ:BIIB) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 1 year agoA look at the shareholders of Biogen Inc. (NASDAQ:BIIB) can tell us which group is most powerful....